Search Results - "Sabe, N."

Refine Results
  1. 1

    Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients by Padullés, A, Colom, H, Bestard, O, Melilli, E, Sabé, N, Rigo, R, Niubó, J, Torras, J, Lladó, L, Manito, N, Caldés, A, Cruzado, J M, Grinyó, J M, Lloberas, N

    Published in Antimicrobial agents and chemotherapy (01-04-2016)
    “…Treatment of solid-organ transplant (SOT) patients with ganciclovir (GCV)-valganciclovir (VGCV) according to the manufacturer's recommendations may result in…”
    Get full text
    Journal Article
  2. 2

    Clinical Features and Outcomes of Tuberculosis in Solid Organ Transplant Recipients by Bodro, M, Sabé, N, Santín, M, Cruzado, J.M, Lladó, L, González-Costello, J, Carratalà, J

    Published in Transplantation proceedings (01-11-2012)
    “…Abstract Background Tuberculosis (TB) remains a significant opportunistic infection in solid organ transplant (SOT) recipients. Moreover, its optimal treatment…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Rifabutin for treating tuberculosis in solid organ transplant recipients: A retrospective observational study and literature review by Gomila‐Grange, A., Pérez‐Recio, S., Camprubí‐Ferrer, D., Lladó, L., Fava, A., García‐Romero, E., Grijota‐Camino, M. D., Sabé, N., Santin, M.

    Published in Transplant infectious disease (01-04-2021)
    “…Background The treatment of tuberculosis (TB) in solid organ transplant (SOT) recipients is challenging owing to interactions between rifampin and…”
    Get full text
    Journal Article
  4. 4

    Donor‐transmitted malaria after heart transplant managed successfully with artesunate by Sabé, N., González‐Costello, J., Oriol, I., Sánchez‐Salado, J.C., Ortega, S., Oliver, E., Manito, N., Carratalà, J.

    Published in Transplant infectious disease (01-12-2014)
    “…Donor‐transmitted malaria is a rare complication in solid organ transplantation, which causes high mortality. Data concerning the use of artesunate in solid…”
    Get full text
    Journal Article
  5. 5

    Successful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors by Sabé, N, González-Costello, J, Rama, I, Niubó, J, Bodro, M, Roca, J, Cruzado, J M, Manito, N, Carratalà, J

    Published in Transplant international (01-07-2012)
    “…Ganciclovir-resistant (GanR) cytomegalovirus (CMV) infection after organ transplantation is emerging as a significant therapeutic challenge. We report two…”
    Get more information
    Journal Article
  6. 6

    Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia by MYKIETIUK, A, CARRATALA, J, DOMINGUEZ, A, MANZUR, A, FERNANDEZ-SABE, N, DORCA, J, TUBAU, F, MANRESA, F, GUDIOL, F

    “…The aim of this study was to evaluate the effect of prior pneumococcal vaccination on the clinical outcome of 554 consecutive hospitalized adults with…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation by Len, O., Montejo, M., Cervera, C., Fariñas, M.C., Sabé, N., Ramos, A., Cordero, E., Torre-Cisneros, J., Martín-Dávila, P., Azanza, J.R., Pahissa, A., Gavaldà, J.

    Published in Transplant infectious disease (01-08-2014)
    “…Introduction Infections caused by resistant gram‐positive cocci (GPC), especially to glycopeptides, are difficult to treat in solid organ transplant (SOT)…”
    Get full text
    Journal Article
  9. 9

    Candida arteritis occurring in a liver transplant recipient by Lladó, L., Solé, C., Bodro, M., Baliellas, C., Sabé, N., Petit, A., Ramos, E., Carratalà, J., Fabregat, J.

    Published in Transplant infectious disease (01-06-2014)
    “…We report the first case, to our knowledge, of Candida arteritis in a liver transplant recipient. The patient presented with hemorrhagic shock requiring…”
    Get full text
    Journal Article
  10. 10

    Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy by Mykietiuk, Analía, Carratalà, Jordi, Fernández-Sabé, Núria, Dorca, Jordi, Verdaguer, Ricard, Manresa, Frederic, Gudiol, Francesc

    Published in Clinical infectious diseases (15-03-2005)
    “…Background. Although the reduction in case-fatality rate recently observed among patients with Legionella pneumonia has been largely attributed to the…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Is hospital-acquired pneumonia different in transplant recipients? by Gudiol, C., Sabé, N., Carratalà, J.

    Published in Clinical microbiology and infection (01-10-2019)
    “…Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are serious complications in transplant patients. The aim of this review is to…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Long-Term Follow-Up Trial of Oral Rifampin-Cotrimoxazole Combination versus Intravenous Cloxacillin in Treatment of Chronic Staphylococcal Osteomyelitis by EUBA, G, MURILLO, O, FERNANDEZ-SABE, N, MASCARO, J, CABO, J, PEREZ, A, TUBAU, F, VERDAGUER, R, GUDIOL, F, ARIZA, J

    Published in Antimicrobial Agents and Chemotherapy (01-06-2009)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  16. 16

    Clinical impact of culture-positive preservation fluid on solid organ transplantation: A systematic review and meta-analysis by Oriol, Isabel, Sabé, N., Tebé, C., Veroux, M., Boin, I.F.S.F., Carratalà, J.

    “…Contamination of the preservation fluid (PF) used for donated organs is a potential source of post-transplant infection. However, the information on this issue…”
    Get full text
    Journal Article
  17. 17

    Early mortality in patients with community-acquired pneumonia: causes and risk factors by Garcia-Vidal, C, Fernandez-Sabe, N, Carratala, J, Diaz, V, Verdaguer, R, Dorca, J, Manresa, F, Gudiol, F

    Published in The European respiratory journal (01-09-2008)
    “…The first 48 h of evolution of patients with community-acquired pneumonia (CAP) are critical. The aim of the present study was to determine the frequency,…”
    Get full text
    Journal Article
  18. 18

    Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection by Cordero, E., Pérez-Romero, P., Moreno, A., Len, O., Montejo, M., Vidal, E., Martín-Dávila, P., Fariñas, M.C., Fernández-Sabé, N., Giannella, M., Pachón, J.

    Published in Clinical microbiology and infection (01-01-2012)
    “…Solid organ transplant recipients (SOTR) are at risk of serious influenza-related complications. The impact of respiratory co-infection in SOTR with 2009…”
    Get full text
    Journal Article
  19. 19

    Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization by Peña, C., Fernández-Sabe, N., Domı́nguez, M.A., Pujol, M., Martinez-Castelao, A., Ayats, J., Gudiol, F., Ariza, J.

    Published in The Journal of hospital infection (01-09-2004)
    “…We performed a prospective study of Staphylococcus aureus nasal carriage in patients on chronic haemodialysis to determine the role of cutaneous colonization…”
    Get full text
    Journal Article
  20. 20

    Aetiology of, and risk factors for, recurrent community-acquired pneumonia by Garcia-Vidal, C., Carratalà, J., Fernández-Sabé, N., Dorca, J., Verdaguer, R., Manresa, F., Gudiol, F.

    Published in Clinical microbiology and infection (01-11-2009)
    “…Recurrent community-acquired pneumonia (CAP) requiring hospitalization is a matter of particular concern. However, current information on its prevalence,…”
    Get full text
    Journal Article